Encompass Health EHC NYSE · Healthcare · United States
$140.97 +0.10% +$0.14
Summary
76 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 27% a year over the last 3 years.
- It earns 14 USD a year on every 100 USD of invested capital.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBy our assumptions the price matches the value of the business: the two differ by less than 10 %.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 21.4 USD for 1 USD of yearly profit. Over the last five years it was 18.8 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 11% a year. For the next fiscal year analysts expect revenue to grow by 9.1%.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 61 USD
- Sales and administration 20 USD
- Taxes and other 8.2 USD
- Net profit 10 USD
Net profit, industry median (Medical - Care Facilities) 7.3 USD
Out of every 100 USD of revenue, 10 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 6.1 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.55%
- Paid out of profit
- 12%
- Raised in a row
- 2 years
You receive $0.78 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 22
- Hold 4
- Sell 1
Today's price within the analysts' price targets
The average target of $154 is 9.2% above today's price. 81% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Inpatient 97%
- Other 3.0%
By region
The company reports no revenue by region.
Inpatient brings in 97% of revenue.
Segments in detail